Kobayashi Norihiro, Shibusawa Kazuki, Kubota Kazuyuki, Hasegawa Noriko, Sun Pi, Niwa Toshifumi, Goto Junichi
Graduate School of Pharmaceutical Sciences, Tohoku University, Aobayama, Aoba-ku, 980-8578, Sendai, Japan.
J Immunol Methods. 2003 Mar 1;274(1-2):63-75. doi: 10.1016/s0022-1759(02)00501-x.
Anti-idiotype antibodies recognizing the variable regions of a particular anti-hapten antibody are valuable tools, which can be used in sensitive hapten immunoassays based on a noncompetitive format. Here, we describe the production and characterization of monoclonal anti-idiotype antibodies against idiotopes on the variable regions of an antibody showing high affinity and specificity to 11-deoxycortisol (11-DC). 11-DC is the biosynthetic precursor of cortisol and a diagnostic index for the assessment of pituitary-adrenal function. BALB/c or A/J mice were repeatedly immunized with the anti-11-DC antibody conjugated with keyhole limpet hemocyanin and their spleen cells were then fused with P3/NS1/1-Ag4-1 myeloma cells. Seven kinds of anti-idiotype antibodies were generated, one of which was a beta-type antibody recognizing the paratope and others which were alpha-type antibodies recognizing the framework region. A noncompetitive ELISA based on idiotype-anti-idiotype reactions was established using one of these alpha-type antibodies in combination with the beta-type antibody and with the anti-11-DC antibody. This noncompetitive assay system provided improved sensitivity (detection limit: 1.0 pg=2.9 fmol), which is approximately 10 times higher than the corresponding competitive enzyme immunoassay, and offered a practical specificity for clinical use. Appropriate serum 11-DC levels were obtained for normal subjects [0.16+/-0.09 (S.D.) microg/l (n=6), ranging from 0.086 to 0.316 microg/l] using the present assay system.
识别特定抗半抗原抗体可变区的抗独特型抗体是有价值的工具,可用于基于非竞争模式的灵敏半抗原免疫测定。在此,我们描述了针对对11-脱氧皮质醇(11-DC)具有高亲和力和特异性的抗体可变区独特位的单克隆抗独特型抗体的制备及特性鉴定。11-DC是皮质醇的生物合成前体,也是评估垂体-肾上腺功能的诊断指标。用与钥孔血蓝蛋白偶联的抗11-DC抗体反复免疫BALB/c或A/J小鼠,然后将其脾细胞与P3/NS1/1-Ag4-1骨髓瘤细胞融合。产生了七种抗独特型抗体,其中一种是识别互补位的β型抗体,其他是识别构架区的α型抗体。使用其中一种α型抗体与β型抗体以及抗11-DC抗体相结合,建立了基于独特型-抗独特型反应的非竞争ELISA。这种非竞争测定系统提供了更高的灵敏度(检测限:1.0 pg = 2.9 fmol),约为相应竞争酶免疫测定的10倍,并且在临床应用中具有实际的特异性。使用本测定系统获得了正常受试者的适当血清11-DC水平[0.16±0.09(标准差)μg/l(n = 6),范围为0.086至0.316 μg/l]。